Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bouffioux

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Acta Urologica Belgica|December 1, 1994
The experience of the CHU Liège with conservative surgery in the management of upper urinary tract tumorsC Bouffioux, R Andrianne, P Bonnet, et al.
European Urology|June 1, 2000
Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary GroupK H Kurth, C Bouffioux, R Sylvester, et al.
British Journal of Cancer|February 1, 1995
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary GroupP H De Mulder, G Oosterhof, C Bouffioux, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Factors affecting recurrence and progression in superficial bladder tumoursK H Kurth, L Denis, C Bouffioux, et al.
The Journal of Urology|March 1, 1995
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary GroupC Bouffioux, K H Kurth, A Bono, et al.
The Journal of Urology|December 1, 1996
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder CancerA Pawinski, R Sylvester, K H Kurth, et al.
The Journal of Urology|August 1, 1992
Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European organization for research on treatment of cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary GroupC Bouffioux, L Denis, W Oosterlinck, et al.
Progress in Clinical and Biological Research|January 1, 1992
Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions)C Bouffioux, A van der Meijden, K H Kurth, et al.
International Journal of Cancer|February 15, 1983
Radioimmunoassay of prostatic acid phosphatase: validation and clinical applicationP Franchimont, C Bouffioux, A Reuter, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Optimal staging procedures, including imaging, to define prognosis of bladder cancerD Paulson, L Denis, S Orikasa, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Acta Urologica Belgica|December 1, 1994
The experience of the CHU Liège with conservative surgery in the management of upper urinary tract tumorsC Bouffioux, R Andrianne, P Bonnet, et al.
European Urology|June 1, 2000
Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary GroupK H Kurth, C Bouffioux, R Sylvester, et al.
British Journal of Cancer|February 1, 1995
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary GroupP H De Mulder, G Oosterhof, C Bouffioux, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Factors affecting recurrence and progression in superficial bladder tumoursK H Kurth, L Denis, C Bouffioux, et al.
The Journal of Urology|March 1, 1995
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary GroupC Bouffioux, K H Kurth, A Bono, et al.
The Journal of Urology|December 1, 1996
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder CancerA Pawinski, R Sylvester, K H Kurth, et al.
The Journal of Urology|August 1, 1992
Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European organization for research on treatment of cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary GroupC Bouffioux, L Denis, W Oosterlinck, et al.
Progress in Clinical and Biological Research|January 1, 1992
Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions)C Bouffioux, A van der Meijden, K H Kurth, et al.
International Journal of Cancer|February 15, 1983
Radioimmunoassay of prostatic acid phosphatase: validation and clinical applicationP Franchimont, C Bouffioux, A Reuter, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Optimal staging procedures, including imaging, to define prognosis of bladder cancerD Paulson, L Denis, S Orikasa, et al.
Pageof 10